anti mitf (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
94
Structured Review
Santa Cruz Biotechnology
anti mitf
Anti Mitf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 331 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mitf/MITF+Antibody/pmc12981246-181-26-30
Average 94 stars, based on 331 article reviews
Anti Mitf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 331 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mitf/MITF+Antibody/pmc12981246-181-26-30
Average 94 stars, based on 331 article reviews
anti mitf - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Incubation:Article Title: IMMUNOSARC II master trial: phase II study of sunitinib and nivolumab in clear cell sarcoma cohort Article Snippet: To block nonspecific binding, sections were incubated with 1% blocking reagent (11096176001; Roche, Germany) diluted in PBS. .. Slides were then incubated at 4°C in a humidified chamber with one of the following primary antibodies: anti-5'-methylthioadenosine phosphorylase (MTAP) (1:4,000, overnight; 11475-1- AP; Proteintech, USA), Article Title: Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma Article Snippet: .. Anti-TG2 (Rabbit, #3557 Cell signaling Technologies) and Article Title: Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma. Article Snippet: .. Anti-TG2 (Rabbit, #3557 Cell signaling Technologies) and Article Title: IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort Article Snippet: Endogenous peroxidase activity was quenched by immersing the sections in an aqueous hydrogen peroxide solution (DS9800; Blocking Peroxidase Reagent; Leica Biosystems, Germany) for 10 min. To block nonspecific binding, sections were incubated with 1% blocking reagent (11,096,176,001; Roche, Germany) diluted in phosphate-buffered saline. .. Slides were then incubated at 4 °C in a humidified chamber with one of the following primary antibodies: anti-5′-methylthioadenosine phosphorylase (MTAP) (1:4,000, overnight; 11475-1-AP; Proteintech, USA), Control:Article Title: SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells Article Snippet: .. 0.5 μg of control antibodies (IgG and H3K4me3) was used as recommended and 1 μg of anti-BRD4 (EpiCypher 13-2003), other:Article Title: SETD6 Mediates Selective Interaction and Genomic Occupancy of BRD4 and MITF in Melanoma cells Article Snippet: 0.5μg of controls antibodies (IgG and H3K4me3) were used as recommended and 1μg of anti-BRD4 (EpiCypher 13-2003), |